Combinatorial Treatment using Targeted MEK and SRC Inhibitors Synergistically Abrogates Tumor Cell Growth and Induces Mesenchymal-Epithelial Transition in Non-Small-Cell Lung Carcinoma. (Oncotarget, Aug 2015)

Chua KN1, Kong LR1, Sim WJ2, Ng HC2, Ong WR3, Thiery JP1,2,4, Huynh H3, Goh BC1,5,6. 1 Cancer Science Institute of Singapore, National University of Singapore, Singapore. 2 Institute of Molecular and Cell Biology, A*STAR, Singapore. 3 National Cancer Centre, Singapore. 4 Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore,

CSI Principal Investigators Receive Top National Honours for Outstanding Research Contributions

CSI Singapore congratulates Professor Patrick Tan, Professor Teh Bin Tean and Dr Yvonne Tay!  Young Scientist Award Recognition for Pioneering Work on Non-Coding RNAs CSI Principal Investigator Dr Yvonne Tay has received the 2015 Young Scientist Award for her outstanding work on non-coding RNAs, which has contributed to a better understanding of the roles that